[1]
Wełnicki , M. and Mamcarz , A. 2019. The use of cilostazol in peripheral arterial disease – indications and controversies. Medycyna Faktow (J EBM). 12, 3(44) (Sep. 2019), 218-224. DOI:https://doi.org/10.24292/01.MF.0319.5.